Mary P. Bronner
No Rating Available
(Learn About Our Rating System)

Mary P. Bronner, MD

Languages spoken: English

Mary P. Bronner, MD, is the Carl R. Kjeldsberg Presidential Endowed Chair Professor of Pathology. She is also a tenured professor of pathology at the University of Utah School of Medicine.



At the Department of Pathology and ARUP Laboratories, and HCI, Dr. Bronner directs all patient care, education, and research efforts within the Anatomic Pathology and Molecular Oncology Division. Her research focuses on molecular oncology and early detection and prevention of gastrointestinal neoplasia arising in chronic inflammatory diseases, such as chronic pancreatitis, Helicobacter pylori gastritis and idopathic inflammatory bowel disease.

Dr. Bronner holds the Dr. Carl R. Kjeldsberg Presidential Endowed Chair in Pathology. She served as the elected President of the GI Pathology Society, and as an elected Council Memeber of the United States and Canadian Academy of Pathology. She was the recipient of the prestigious Arthur Purdy Stout Prize, which recognizes surgical pathologists under the age of 45 whose research have had a major impact on diagnostic pathology. Dr. Bronner is also certified by the American Board of Pathology in Anatomic Pathology. She completed her pathology residency training and chief residency at the Hospital of the University of Pennsylvania in Philadelphia. She received her medical degree from the University of Pennsylvania and has been on the faculty at the University of Pennsylvania, the University of Washington, the Cleveland Clinic Foundation prior to joining the University of Utah and ARUP Laboratories.

Specialties

  • Gastrointestinal Pathology
  • Surgical Pathology
  • Molecular Pathology
  • Pathology, Anatomical

Board Certification

American Board of Pathology (Anatomic)

Mary P. Bronner, MD, is the Carl R. Kjeldsberg Presidential Endowed Chair Professor of Pathology. She is also a tenured professor of pathology at the University of Utah School of Medicine.



At the Department of Pathology and ARUP Laboratories, and HCI, Dr. Bronner directs all patient care, education, and research efforts within the Anatomic Pathology and Molecular Oncology Division. Her research focuses on molecular oncology and early detection and prevention of gastrointestinal neoplasia arising in chronic inflammatory diseases, such as chronic pancreatitis, Helicobacter pylori gastritis and idopathic inflammatory bowel disease.

Dr. Bronner holds the Dr. Carl R. Kjeldsberg Presidential Endowed Chair in Pathology. She served as the elected President of the GI Pathology Society, and as an elected Council Memeber of the United States and Canadian Academy of Pathology. She was the recipient of the prestigious Arthur Purdy Stout Prize, which recognizes surgical pathologists under the age of 45 whose research have had a major impact on diagnostic pathology. Dr. Bronner is also certified by the American Board of Pathology in Anatomic Pathology. She completed her pathology residency training and chief residency at the Hospital of the University of Pennsylvania in Philadelphia. She received her medical degree from the University of Pennsylvania and has been on the faculty at the University of Pennsylvania, the University of Washington, the Cleveland Clinic Foundation prior to joining the University of Utah and ARUP Laboratories.

Board Certification and Academic Information

Academic Departments Pathology -Professor
Board Certification
American Board of Pathology (Anatomic)

Education history

Undergraduate Biology & Genetics with Honors - Cornell University B.S.
Professional Medical Medicine - University of Pennsylvania M.D.
Fellowship Wistar Institute Research - University of Pennsylvania Fellow
Fellowship Anatomic Pathology Student Fellowship - Hospital of the University of Pennsylvania Fellow

Selected Publications

Journal Article

  1. Bronner MP, Clevenger CV, Edmonds PR, Lowell DM, McFarland MM, LiVolsi VA (1988). Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid. Am J Clin Pathol, 89(6), 764-9.
  2. Lamps LW, Bronner MP, Vnencak-Jones CL, Tham KT, Mertz HR, Scott MA (1998). Optimal screening and diagnosis of microsporida in tissue sections: a comparison of polarization, special stains, and molecular techniques. Am J Clin Pathol, 109(4), 404-10.
  3. Robert ME, Washington MK, Lee JR, Goldenring JR, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart JA, Lamps LW, Lauwers GY, Lewin D, Lazenby AJ, Montgomery E, Crawford J (2005). Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus. American journal of clinical pathology, 124(4), 519-27.
  4. Cotler SJ, Taylor SL, Gretch DR, Bronner MP, Rizk R, Perkins JD, Carithers RL J (2000). Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients. The American journal of gastroenterology, 95(3), 753-9.
  5. Montgomery E, Bronner MP, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Goldblum J (2002). Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up. The American journal of gastroenterology, 97(1), 27-31.
  6. Downs-Kelly E, Mendelin JE, Bennett AE, Castilla E, Henricks WH, Schoenfield L, Skacel M, Yerian L, Rice TW, Rybicki LA, Bronner MP, Goldblum J (2008). Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. The American journal of gastroenterology, 103(9), 2333-40; quiz 2341.
  7. Allende DS, Taylor SL, Bronner M (2008). Colonic perforation as a complication of collagenous colitis in a series of 12 patients. The American journal of gastroenterology, 103(10), 2598-604.
  8. Edelstein ZR, Bronner MP, Rosen SN, Vaughan T (2009). Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study. The American journal of gastroenterology, 104(4), 834-42.
  9. Albashir S, Bronner MP, Parsi MA, Walsh RM, Stevens (2010). Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis. The American journal of gastroenterology, 105(11), 2498-503.
  10. Eberle MA, Pfützer R, Pogue-Geile KL, Bronner MP, Crispin D, Kimmey MB, Duerr RH, Kruglyak L, Whitcomb DC, Brentnall T (2002). A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. American journal of human genetics, 70(4), 1044-8.
  11. Maronian N, Haggitt R, Oelschlager BK, Bronner M, Yang J, Reyes V, Hillel A, Eubanks T, Pellegrini CA, Pope CE 2n (2003). Histologic features of reflux-attributed laryngeal lesions. The American journal of medicine, 115 Suppl 3A, 105S-108S.
  12. Bronner MP, Culin C, Reed JC, Furth E (1995). The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. The American journal of pathology, 146(1), 20-6.
  13. Agoff SN, Brentnall TA, Crispin DA, Taylor SL, Raaka S, Haggitt RC, Reed MW, Afonina IA, Rabinovitch PS, Stevens AC, Feng Z, Bronner M (2000). The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. The American journal of pathology, 157(3), 737-45.
  14. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Koprowicz KM, Bronner MP, Brentnall T (2003). DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. The American journal of pathology, 162(2), 665-72.
  15. Bronner MP, O'Sullivan JN, Rabinovitch PS, Crispin DA, Chen L, Emond MJ, Rubin CE, Brentnall T (2008). Genomic biomarkers to improve ulcerative colitis neoplasia surveillance. The American journal of pathology, 173(6), 1853-60.
  16. Valdez R, Appelman HD, Bronner MP, Greenson J (2000). Diffuse duodenitis associated with ulcerative colitis. The American journal of surgical pathology, 24(10), 1407-13.
  17. Meckler KA, Brentnall TA, Haggitt RC, Crispin D, Byrd DR, Kimmey MB, Bronner M (2001). Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma. The American journal of surgical pathology, 25(8), 1047-53.
  18. Lamps LW, Madhusudhan KT, Havens JM, Greenson JK, Bronner MP, Chiles MC, Dean PJ, Scott M (2003). Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn's disease. The American journal of surgical pathology, 27(2), 220-7.
  19. Yuan S, Reyes V, Bronner M (2003). Pseudomembranous collagenous colitis. The American journal of surgical pathology, 27(10), 1375-9.
  20. Akintola-Ogunremi O, Pfeifer JD, Tan BR, Yan Y, Zhu X, Hart J, Goldblum JR, Burgart L, Lauwers GY, Montgomery E, Lewin D, Washington K, Bronner M, Xiao SY, Greenson JK, Lamps L, Lazenby A, Wang H (2003). Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas. The American journal of surgical pathology, 27(12), 1551-8.
  21. Allison KH, Yoder BJ, Bronner MP, Goldblum JR, Rubin B (2004). Angiosarcoma involving the gastrointestinal tract: a series of primary and metastatic cases. The American journal of surgical pathology, 28(3), 298-307.
  22. Cho MY, Kim HS, Eng C, Kim DS, Kang SJ, Eom M, Yi SY, Bronner M (2008). First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity. The American journal of surgical pathology, 32(8), 1258-64.
  23. Boncher J, Bronner M, Goldblum JR, Liu (2011). Reticulin staining clarifies florid benign signet ring cell change with mitotic activity in a penetrating gastric ulcer. The American journal of surgical pathology, 35(5), 762-6.
  24. Ondrejka SL, Schaeffer DF, Jakubowski MA, Owen DA, Bronner M (2011). Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing?. The American journal of surgical pathology, 35(9), 1327-30.
  25. Patil DT, Goldblum JR, Rybicki L, Plesec TP, Mendelin JE, Bennett AE, Castilla EA, Henricks WH, Schoenfield L, Skacel M, Yerian LM, Rice TW, Bronner MP, Downs-Kelly (2012). Prediction of adenocarcinoma in esophagectomy specimens based upon analysis of preresection biopsies of Barrett esophagus with at least high-grade dysplasia: a comparison of 2 systems. The American journal of surgical pathology, 36(1), 134-41.
  26. Lin J, Goldblum JR, Bennett AE, Bronner MP, Liu (2012). Composite intestinal adenoma-microcarcinoid. The American journal of surgical pathology, 36(2), 292-5.
  27. Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey M (1999). Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Annals of internal medicine, 131(4), 247-55.
  28. Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall T (2001). Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Annals of internal medicine, 134(2), 89-95.
  29. Jobe BA, O'Rourke RW, McMahon BP, Gravesen F, Lorenzo C, Hunter JG, Bronner M, Kraemer S (2008). Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Annals of surgery, 248(1), 69-76.
  30. MacCalman CD, Furth EE, Omigbodun A, Bronner M, Coutifaris C, Strauss J (1996). Regulated expression of Cadherin-11 in human epithelial cells: A role for Cadherin-11 in trophoblast-endometrium interactions?. Developmental dynamics, 206, 201-211.
  31. Bell K, Bronner MP, Pasha T, Furth E (1996). Expression of proliferating cell nuclear antigen in gastrointestinal tract lesions and its relationship to bcl-2 expression. Pathobiology, 64(2), 91-8.
  32. Moskovitz AH, Linford NJ, Brentnall TA, Bronner MP, Storer BE, Potter JD, Bell RH Jr, Rabinovitch P (2003). Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma. Genes, chromosomes & cancer, 37(2), 201-6.
  33. Affolter K, Samowitz W, Tripp S, Bronner M (2013). BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma. Genes, chromosomes & cancer, 52(8), 748-52.
  34. Kanth P, Hazel MW, Boucher KM, Yang Z, Wang L, Bronner MP, Boylan KE, Burt RW, Westover M, Neklason DW, Delker D (2019). Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer. Genes, chromosomes & cancer, 58(1), 23-33.
  35. Davis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsh C (1995). Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder. Clinical transplantation, 9(1), 53-9.
  36. Charpentier KP, Brentnall TA, Bronner MP, Byrd D, Marsh (2004). A new indication for pancreas transplantation: high grade pancreatic dysplasia. Clinical transplantation, 18(1), 105-7.
  37. Pickett CA, Agoff SN, Widman TJ, Bronner M (2005). Altered expression of cyclins and cell cycle inhibitors in papillary thyroid cancer: prognostic implications. Thyroid, 15(5), 461-73.
  38. Rudolph RE, Dominitz JA, Lampe JW, Levy L, Qu P, Li SS, Lampe PD, Bronner MP, Potter J (2005). Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer epidemiology, biomarkers & prevention, 14(3), 605-8.
  39. O'Sullivan J, Risques RA, Mandelson MT, Chen L, Brentnall TA, Bronner MP, Macmillan MP, Feng Z, Siebert JR, Potter JD, Rabinovitch P (2006). Telomere length in the colon declines with age: a relation to colorectal cancer?. Cancer epidemiology, biomarkers & prevention, 15(3), 573-7.
  40. Yasui Y, Potter JD, Stanford JA, Rossing MA, Winget MD, Bronner MP, Daling (2001). Breast cancer risk and `delayed¿ primary Epstein-Barr virus infection. Cancer epidemiology, biomarkers & prevention, 10, 9-16.
  41. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH, Crispin DA, Potter JD, Rabinovitch P (2002). Chromosomal instability in ulcerative colitis is related to telomere shortening. Nature genetics, 32(2), 280-4.
  42. Patil DT, Bronner MP, Portier BP, Fraser CR, Plesec TP, Liu (2012). A five-marker panel in a multiplex PCR accurately detects microsatellite instability-high colorectal tumors without control DNA. Diagnostic molecular pathology, 21(3), 127-33.
  43. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Bronner MP, Brentnall T (2005). The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis, 26(9), 1513-9.
  44. Chen R, Bronner MP, Crispin DA, Rabinovitch PS, Brentnall T (2005). Characterization of genomic instability in ulcerative colitis neoplasia leads to discovery of putative tumor suppressor regions. Cancer genetics and cytogenetics, 162(2), 99-106.
  45. Lai LA, Risques RA, Bronner MP, Rabinovitch PS, Crispin D, Chen R, Brentnall T (2012). Pan-colonic field defects are detected by CGH in the colons of UC patients with dysplasia/cancer. Cancer letters, 320(2), 180-8.
  46. Brentnall TA, Chen R, Lee JG, Kimmey MB, Bronner MP, Haggitt RC, Kowdley KV, Hecker LM, Byrd D (1995). Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer research, 55(19), 4264-7.
  47. Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, Rubin CE, Haggitt RC, Boland C (1996). Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer research, 56(6), 1237-40.
  48. Rabinovitch PS, Dziadon S, Brentnall TA, Emond MJ, Crispin DA, Haggitt RC, Bronner M (1999). Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer research, 59(20), 5148-53.
  49. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall T (2001). Accelerated age-related CpG island methylation in ulcerative colitis. Cancer research, 61(9), 3573-7.
  50. Risques RA, Lai LA, Himmetoglu C, Ebaee A, Li L, Feng Z, Bronner MP, Al-Lahham B, Kowdley KV, Lindor KD, Rabinovitch PS, Brentnall T (2011). Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer research, 71(5), 1669-79.
  51. Dumartin L, Whiteman HJ, Weeks ME, Hariharan D, Dmitrovic B, Iacobuzio-Donahue CA, Brentnall TA, Bronner MP, Feakins RM, Timms JF, Brennan C, Lemoine NR, Crnogorac-Jurcevic (2011). AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Cancer research, 71(22), 7091-102.
  52. Law R, Bronner M, Vogt D, Stevens (2009). Autoimmune pancreatitis: a mimic of pancreatic cancer. Cleveland Clinic journal of medicine, 76, 607-615.
  53. Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley K (1999). Quantitative study of the variability of hepatic iron concentrations. Clinical chemistry, 45(3), 340-6.
  54. Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church J (2008). Identifying Lynch syndrome: we are all responsible. Diseases of the colon and rectum, 51(12), 1750-6.
  55. Samadder, NJ, Valentine JF, Guthery S, Singh H, Bernstein C, Wan Y, Wong J, Boucher K, Pappas L, Rowe K, Bronner M, Ulrich N, Burt RW, Curtin K and Smith K (2017). Colorectal cancer in inflammatory bowel diseases: A population-based study in Utah. Digestive diseases and sciences, 62(8), 2126-2132.
  56. Wittmaack FM, Gafvels ME, Bronner M, Matsuo H, McCrae KR, Tomaszewski JE, Robinson SL, Strickland DK, Strauss JF 3r (1995). Localization and regulation of the human very low density lipoprotein/apolipoprotein-E receptor: trophoblast expression predicts a role for the receptor in placental lipid transport. Endocrinology, 136(1), 340-8.
  57. Shaheen NJ, Peery AF, Hawes RH, Rothstein RI, Spechler SJ, Galanko JA, Campbell M, Carr C, Fowler B, Walsh J, Siddiqui AA, Infantolino A, Wolfsen HC, Bronner MP, AIM Dysplasia Trial Investigator (2010). Quality of life following radiofrequency ablation of dysplastic Barrett's esophagus. Endoscopy, 42, 790-799.
  58. Pan S, Chen R, Reimel BA, Crispin DA, Mirzaei H, Cooke K, Coleman JF, Lane Z, Bronner MP, Goodlett DR, McIntosh MW, Traverso W, Aebersold R, Brentnall T (2009). Quantitative proteomics investigation of pancreatic intraepithelial neoplasia. Electrophoresis, 30(7), 1132-44.
  59. Brentnall TA, Rubin CE, Crispin DA, Stevens A, Batchelor RH, Haggitt RC, Bronner MP, Evans JP, McCahill LE, Bilir (1995). A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology, 109(1), 151-5.
  60. Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, Kowdley KV, Stevens AC, Crispin DA, Emond M, Rubin C (1996). Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology, 110(2), 331-8.
  61. Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley K (2003). Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology, 124(2), 318-26.
  62. Chen R, Yi EC, Donohoe S, Pan S, Eng J, Cooke K, Crispin DA, Lane Z, Goodlett DR, Bronner MP, Aebersold R, Brentnall T (2005). Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology, 129(4), 1187-97.
  63. Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan T (2007). Central adiposity and risk of Barrett's esophagus. Gastroenterology, 133(2), 403-11.
  64. Risques RA, Lai LA, Brentnall TA, Li L, Feng Z, Gallaher J, Mandelson MT, Potter JD, Bronner MP, Rabinovitch P (2008). Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology, 135(2), 410-8.
  65. Bronner MP, Overholt BF, Taylor SL, Haggitt RC, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, Sivak MV, Nishioka N, Barr H, Canto MI, Marcon N, Pedrosa M, Grace M, Depot (2009). Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology, 136(1), 56-64; quiz 351-2.
  66. Shaheen NJ, Overholt BF, Sampliner RE, Wolfsen HC, Wang KK, Fleischer DE, Sharma VK, Eisen GM, Fennerty MB, Hunter JG, Bronner MP, Goldblum JR, Bennett AE, Mashimo H, Rothstein RI, Gordon SR, Edmundowicz SA, Madanick RD, Peery AF, Muthusamy VR, Chang KJ, Kimmey MB, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Dumot JA, Falk GW, Galanko JA, Jobe BA, Hawes RH, Hoffman BJ, Sharma P, Chak A, Lightdale C (2011). Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology, 141(2), 460-8.
  67. Kim B-W, Cho M-Y, Lee B, Shadrach B, Shergill U, Welker N, Crispin D, Shimoda S, Peng X, Li J, Bronner MP (2013 (2016). FISH Biomarkers of Gastric Cancer Risk in Helicobacter Pylori Intestinalized Pangastritis. Gastroenterology,
  68. Kimmey MB, Bronner MP, Byrd DR, Brentnall T (2002). Screening and surveillance for hereditary pancreatic cancer. Gastrointestinal endoscopy, 56(4 Suppl), S82-6.
  69. Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, Bronner MP, Taylor SL, Grace MG, Depot (2005). Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointestinal endoscopy, 62(4), 488-98.
  70. Overholt BF, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, Sivak MV Jr, Nishioka N, Barr H, Marcon N, Pedrosa M, Bronner MP, Grace M, Depot (2007). Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointestinal endoscopy, 66(3), 460-8.
  71. Cotler SJ, Gretch DR, Bronner MP, Tateyama H, Emond MJ, dela Rosa C, Perkins JD, Carithers RL J (1997). Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients. Hepatology (Baltimore, Md.), 26(2), 432-6.
  72. Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H, Emerson SS, Perkins JD, Carithers RL J (1997). Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology (Baltimore, Md.), 26(6), 1646-52.
  73. Bronner M (2000). Rodger C. Haggitt: A biography. Human pathology, 31(10), 1185-7.
  74. Patil DT, Bennett AE, Mahajan D, Bronner M (2013). Distinguishing Barrett gastric foveolar dysplasia from reactive cardiac mucosa in gastroesophageal reflux disease. Human pathology, 44(6), 1146-53.
  75. Shaco-Levy R, Jasperson KW, Martin K, Samadder NJ, Burt RW, Ying J, Bronner M (2016). Morphologic characterization of hamartomatous gastrointestinal polyps in Cowden syndrome, Peutz-Jeghers syndrome, and juvenile polyposis syndrome. Human pathology, 49, 39-48.
  76. Deftereos G, Sandoval A, Furtado LV, Bronner M, Matynia A (2020). Successful lung cancer EGFR sequencing from DNA extracted from TTF-1 immunohistochemistry slides: a new means to extend insufficient tissue. Human pathology, 97, 52-59.
  77. Dong ZM, Fang J, Byrne KR, Bronner MP, Hale G (2021). Histologic Mimics and Diagnostic Pitfalls of Gastrointestinal Endoscopic Lifting Media, ORISETM gel and Eleview®. Human pathology, 119, 28-40.
  78. Kido S, Sakuragi N, Bronner MP, Sayegh R, Berger R, Patterson D, Strauss JF 3r (1993). D21S418E identifies a cAMP-regulated gene located on chromosome 21q22.3 that is expressed in placental syncytiotrophoblast and choriocarcinoma cells. Genomics, 17(1), 256-9.
  79. Russell CW, Fleming BA, Jost CA, Tran A, Stenquist AT, Wambaugh WA, Bronner MP, Mulvey M (2018). Context-Dependent Requirements for FimH and Other Canonical Virulence Factors in Gut Colonization by Extraintestinal Pathogenic Escherichia coli. Infection and immunity, 86(3), pii: e00746-17.
  80. El Jabbour T, Ross JS, Sheehan CE, Affolter KE, Geiersbach KB, Boguniewicz A, Ainechi S, Bronner MP, Jones DM, Lee (2018). PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry. Journal of clinical pathology, 71(1), 46-51.
  81. Cotler SJ, Emond MJ, Gretch DR, Wilson JJ, Lin M, Bronner MP, Kowdley K (1999). Relationship between iron concentration and hepatitis C virus RNA level in liver tissue. Journal of clinical gastroenterology, 29(4), 322-6.
  82. Shaco-Levy R, Jasperson KW, Martin K, Samadder NJ, Burt RW, Ying J, Bronner M (2017). Gastrointestinal Polyposis in Cowden Syndrome. Journal of clinical gastroenterology, 51(7), e60-e67.
  83. Cotler SJ, Bronner MP, Press RD, Carlson TH, Perkins JD, Emond MJ, Kowdley K (1998). End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. Journal of hepatology, 29(2), 257-62.
  84. Ren DN, Kim IY, Koh SB, Chang SJ, Eom M, Yi SY, Seong SH, Kim MD, Bronner MP, Cho M (2009). Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma. Journal of surgical oncology, 100(7), 546-52.
  85. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale C (2009). Radiofrequency ablation in Barrett's esophagus with dysplasia. The New England journal of medicine, 360(22), 2277-88.
  86. Chen R, Pan S, Cooke K, Moyes KW, Bronner MP, Goodlett DR, Aebersold R, Brentnall T (2007). Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas, 34(1), 70-9.
  87. Chen R, Crispin DA, Pan S, Hawley S, McIntosh MW, May D, Anton-Culver H, Ziogas A, Bronner MP, Brentnall T (2010). Pilot study of blood biomarker candidates for detection of pancreatic cancer. Pancreas, 39(7), 981-8.
  88. Stevens T, Berk MP, Lopez R, Chung YM, Zhang R, Parsi MA, Bronner MP, Feldstein A (2012). Lipidomic profiling of serum and pancreatic fluid in chronic pancreatitis. Pancreas, 41(4), 518-22.
  89. Bronner MP, LiVolsi V (1991). Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. Modern pathology, 4(5), 637-43.
  90. Anwar F, Emond MJ, Schmidt RA, Hwang HC, Bronner M (2000). Retinoblastoma expression in thyroid neoplasms. Modern pathology, 13(5), 562-9.
  91. Agoff SN, Crispin DA, Bronner MP, Dail DH, Hawes SE, Haggitt R (2001). Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Modern pathology, 14(3), 139-46.
  92. Chu KE, Papouchado BG, Lane Z, Bronner M (2009). The role of Movat pentachrome stain and immunoglobulin G4 immunostaining in the diagnosis of autoimmune pancreatitis. Modern pathology, 22(3), 351-8.
  93. Mahajan D, Bennett AE, Liu X, Bena J, Bronner M (2010). Grading of gastric foveolar-type dysplasia in Barrett's esophagus. Modern pathology, 23(1), 1-11.
  94. Bronner MP, Skacel M, Crispin DA, Hoff PD, Emond MJ, Lai LA, Tubbs RR, O'Sullivan JN, Rabinovitch PS, Brentnall T (2010). Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors. Modern pathology, 23(12), 1624-33.
  95. Lin J, Cao Q, Zhang J, Li Y, Shen B, Zhao Z, Chinnaiyan AM, Bronner M (2013). MicroRNA expression patterns in indeterminate inflammatory bowel disease. Modern pathology, 26(1), 148-54.
  96. Lin J, Welker NC, Zhao Z, Li Y, Zhang J, Reuss SA, Zhang X, Lee H, Liu Y, Bronner M (2014). Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity. Modern pathology, 27(4), 602-8.
  97. Sangle NA, Taylor SL, Emond MJ, Depot M, Overholt BF, Bronner M (2015). Overdiagnosis of high-grade dysplasia in Barrett's esophagus: a multicenter, international study. Modern pathology, 28(6), 758-65.
  98. Caliskan A, Kohlmann WK, Affolter KE, Downs-Kelly E, Kanth P, Bronner M (2018). Intramucosal lipomas of the colon implicate Cowden syndrome. Modern pathology, 31(4), 643-651.
  99. Alpert L, Al-Sabti R, Graham RP, Pai RK, Gonzalez RS, Zhang X, Smith V, Wang HL, Westbrook L, Goldblum JR, Bakhshwin A, Shetty S, Klimstra DS, Shia J, Askan G, Robert ME, Thomas C, Frankel WL, Alsomali M, Hagen C, Mostafa ME, Feely MM, Assarzadegan N, Misdraji J, Shih AR, Agostini-Vulaj D, Meis JM, Tang S, Chatterjee D, Kang LI, Hart J, Lee SM, Smith T, Yantiss RK, Hissong EM, Gao ZH, Wu J, Resnick MB, Wu EY, Pai RK, Zhao L, Doyle LA, Chopra S, Panarelli NC, Hu S, Longacre TA, Raghavan SS, Lauwers GY, Ghayouri M, Cooper HS, Nagarathinam R, Bellizzi AM, Kakar S, Hosseini M, Rong J, Greenson JK, Lamps LW, Dong Z, Bronner M (2020). Smooth muscle tumors of the gastrointestinal tract: an analysis of prognostic features in 407 cases. Modern pathology, 33(7), 1410-1419.
  100. Salk JJ, Salipante SJ, Risques RA, Crispin DA, Li L, Bronner MP, Brentnall TA, Rabinovitch PS, Horwitz MS, Loeb L (2009). Clonal expansions in ulcerative colitis identify patients with neoplasia. Proceedings of the National Academy of Sciences of the United States of America, 106(49), 20871-6.
  101. Loeb LA, Kohrn BF, Loubet-Senear KJ, Dunn YJ, Ahn EH, O'Sullivan JN, Salk JJ, Bronner MP, Beckman R (2019). Extensive subclonal mutational diversity in human colorectal cancer and its significance. Proceedings of the National Academy of Sciences of the United States of America, 116(52), 26863-72.
  102. Levine MS, Barnes MJ, Bronner MP, Rubesin SE, Saul S (1990). Atypical hyperplastic polyps at double-contrast barium enema examination. Radiology, 175(3), 691-4.
  103. Rubesin SE, Gilchrist AM, Bronner MP, Saul SH, Herlinger H, Grumbach K, Levine MS, Laufer (1990). Non-Hodgkin lymphoma of the small intestine. Radiographics, 10, 985-998.
  104. Bronner M (2004). Granulomatous appendicitis and the appendix in idiopathic inflammatory bowel disease. Seminars in diagnostic pathology, 21(2), 98-107.
  105. Morrison J, Bronner M, Leach BH, Downs-Kelly E, Goldblum JR, Liu (2011). Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach. Scandinavian journal of gastroenterology, 46(11), 1340-8.
  106. Yen TW, Aardal NP, Bronner MP, Thorning DR, Savard CE, Lee SP, Bell RH J (2002). Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery, 131(2), 129-34.
  107. Cotler SJ, Gaur LK, Gretch DR, Wile M, Strong DM, Bronner MP, Carithers RL Jr, Emond MJ, Perkins JD, Nelson K (1998). Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. Tissue antigens, 52(5), 435-43.
  108. Kendrick EA, McVicar JP, Kowdley KV, Bronner MP, Emond MJ, Alpers CE, Gretch DR, Carithers RL Jr, Perkins JD, Davis C (1997). Renal disease in hepatitis C-positive liver transplant recipients. Transplantation, 63(9), 1287-93.
  109. Stehman-Breen CO, Psaty BM, Emerson S, Gretch D, Bronner MP, Marsh C, Davis C (1997). Association of hepatitis C virus infection with mortality and graft survival in kidney pancreas transplant recipients. Transplantation, 64, 281-286.
  110. Rice TW, Bronner M (2011). The Esophageal Wall. Chest surgery clinics of North America,
  111. Lynam-Lennon N, Bibby BA, Mongan AM, Marignol L, Paxton CN, Geiersbach K, Bronner MP, O'Sullivan J, Reynolds J, Maher S (2016). Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma. Molecular medicine (Cambridge, Mass.), 22,
  112. Sakuragi N, Matsuo H, Coukos G, Furth EE, Bronner MP, VanArsdale CM, Krajewsky S, Reed JC, Strauss JF 3r (1994). Differentiation-dependent expression of the BCL-2 proto-oncogene in the human trophoblast lineage. Journal of the Society for Gynecologic Investigation, 1(2), 164-72.
  113. Bista RK, Brentnall TA, Bronner MP, Langmead CJ, Brand RE, Liu (2011). Using optical markers of nondysplastic rectal epithelial cells to identify patients with ulcerative colitis-associated neoplasia. Inflammatory bowel diseases, 17(12), 2427-35.
  114. Zisman TL, Bronner MP, Rulyak S, Kowdley KV, Saunders M, Lee SD, Ko C, Kimmey MB, Stevens A, Maurer J, Brentnall T (2012). Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines. Inflammatory bowel diseases, 18(12), 2240-6.
  115. Salk JJ, Bansal A, Lai LA, Crispin DA, Ussakli CH, Horwitz MS, Bronner MP, Brentnall TA, Loeb LA, Rabinovitch PS, Risques R (2013). Clonal expansions and short telomeres are associated with neoplasia in early-onset, but not late-onset, ulcerative colitis. Inflammatory bowel diseases, 19(12), 2593-602.
  116. Bronner MP, Goldblum J (2004). Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Advances in anatomic pathology, 11, 225-226.
  117. Schell JC, Wisidagama DR, Bensard C, Zhao H, Wei P, Tanner J, Flores A, Mohlman J, Sorensen LK, Earl CS, Olson KA, Miao R, Waller TC, Delker D, Kanth P, Jiang L, DeBerardinis RJ, Bronner MP, Li DY, Cox JE, Christofk HR, Lowry WE, Thummel CS, Rutter (2017). Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nature cell biology, 19(9), 1027-1036.
  118. Alexander J, Limaye AP, Ko CW, Bronner MP, Kowdley K (2006). Association of hepatic iron overload with invasive fungal infection in liver transplant recipients. Liver transplantation, 12(12), 1799-804.
  119. Affolter KE, Hellwig S, Nix DA, Bronner MP, Thomas A, Fuertes CL, Hamil CL, Garrido-Laguna I, Scaife CL, Mulvihill SJ, Underhill H (2021). Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma. Neoplasia (New York, N.Y.), 23(9), 859-869.
  120. Bronner MP, Hamilton R, LiVolsi V (1994). Utility of frozen section analysis on follicular lesions of the thyroid. Endocrine pathology, 5(3), 154-161.
  121. Chen R, Pan S, Lai K, Lai LA, Crispin DA, Bronner MP, Brentnall T (2014). Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer. World journal of gastroenterology, 20(45), 17037-48.
  122. Mitomi H, Okayasu I, Bronner MP, Kanazawa H, Nishiyama Y, Otani Y, Sada M, Tanabe S, Igarashi M, Katsumata T, Saigenji (2005). Comparative histologic assessment of proctocolectomy specimens from Japanese and American patients with ulcerative colitis with or without dysplasia. International journal of surgical pathology, 13(3), 259-65.
  123. Chen R, Pan S, Yi EC, Donohoe S, Bronner MP, Potter JD, Goodlett DR, Aebersold R, Brentnall T (2006). Quantitative proteomic profiling of pancreatic cancer juice. Proteomics, 6(13), 3871-9.
  124. Chen R, Brentnall TA, Pan S, Cooke K, Moyes KW, Lane Z, Crispin DA, Goodlett DR, Aebersold R, Bronner M (2007). Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Molecular & cellular proteomics, 6(8), 1331-42.
  125. Koh PK, Doumit J, Downs-Kelly E, Bronner MP, Salimi R, Fazio VW, Vogel J (2008). Ileo-anal j-pouch cancer: an unusual case in an unusual location. Techniques in coloproctology, 12(4), 341-5.
  126. Chen R, Pan S, Ottenhof NA, de Wilde RF, Wolfgang CL, Lane Z, Post J, Bronner MP, Willmann JK, Maitra A, Brentnall T (2012). Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer biology & therapy, 13(10), 899-907.
  127. Eisele Y, Mallea PM, Gigic B, Stephens WZ, Warby CA, Buhrke K, Lin T, Boehm J, Schrotz-King P, Hardikar S, Huang LC, Pickron TB, Scaife CL, Viskochil R, Koelsch T, Peoples AR, Pletneva MA, Bronner M, Schneider M, Ulrich AB, Swanson EA, Toriola AT, Shibata D, Li CI, Siegel EM, Figueiredo J, Janssen KP, Hauner H, Round J, Ulrich CM, Holowatyj AN, Ose (2021). Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study. Clinical colorectal cancer, 20(3), e165-e172.
  128. May D, Pan S, Crispin DA, Lai K, Bronner MP, Hogan J, Hockenbery DM, McIntosh M, Brentnall TA, Chen (2011). Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics. Journal of proteome research, 10(1), 200-9.
  129. Pan S, Chen R, Crispin DA, May D, Stevens T, McIntosh MW, Bronner MP, Ziogas A, Anton-Culver H, Brentnall T (2011). Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. Journal of proteome research, 10(5), 2359-76.
  130. Kariv R, Plesec TP, Goldblum JR, Bronner M, Oldenburgh M, Rice TW, Falk G (2009). The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clinical gastroenterology and hepatology, 7(6), 653-8; quiz 606.
  131. Arrossi AV, Kariv Y, Bronner MP, Hammel J, Remzi FH, Fazio VW, Goldblum J (2011). Backwash ileitis does not affect pouch outcome in patients with ulcerative colitis with restorative proctocolectomy. Clinical gastroenterology and hepatology, 9(11), 981-8.
  132. Rice TW, Bronner M (2011). The esophageal wall. Thoracic surgery clinics, 21(2), 299-305, x.
  133. Pogue-Geile KL, Chen R, Bronner MP, Crnogorac-Jurcevic T, Moyes KW, Dowen S, Otey CA, Crispin DA, George RD, Whitcomb DC, Brentnall T (2006). Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS medicine, 3(12), e516.
  134. Underhill HR, Kitzman JO, Hellwig S, Welker NC, Daza R, Baker DN, Gligorich KM, Rostomily RC, Bronner MP, Shendure (2016). Fragment Length of Circulating Tumor DNA. PLoS genetics, 12(7), e1006162.
  135. Runtsch MC, Nelson MC, Lee SH, Voth W, Alexander M, Hu R, Wallace J, Petersen C, Panic V, Villanueva CJ, Evason KJ, Bauer KM, Mosbruger T, Boudina S, Bronner M, Round JL, Drummond MJ, O'Connell R (2019). Anti-inflammatory microRNA-146a protects mice from diet-induced metabolic disease. PLoS genetics, 15(2), e1007970.
  136. Thompson OM, Beresford SA, Kirk EA, Bronner MP, Vaughan T (2010). Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction. Obesity (Silver Spring, Md.), 18(11), 2204-11.
  137. Pan S, Chen R, Stevens T, Bronner MP, May D, Tamura Y, McIntosh MW, Brentnall T (2011). Proteomics portrait of archival lesions of chronic pancreatitis. PloS one, 6(11), e27574.
  138. Brentnall TA, Lai LA, Coleman J, Bronner MP, Pan S, Chen (2012). Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion. PloS one, 7(1), e30219.
  139. Crnogorac-Jurcevic T, Chelala C, Barry S, Harada T, Bhakta V, Lattimore S, Jurcevic S, Bronner M, Lemoine NR, Brentnall T (2013). Molecular analysis of precursor lesions in familial pancreatic cancer. PloS one, 8(1), e54830.
  140. Delker DA, McGettigan BM, Kanth P, Pop S, Neklason DW, Bronner MP, Burt RW, Hagedorn C (2014). RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PloS one, 9(2), e88367.
  141. Nix DA, Hellwig S, Conley C, Thomas A, Fuertes CL, Hamil CL, Bhetariya PJ, Garrido-Laguna I, Marth GT, Bronner MP, Underhill H (2020). The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA. PloS one, 15(2), e0229063.
  142. Hellwig S, Nix DA, Gligorich KM, O'Shea JM, Thomas A, Fuertes CL, Bhetariya PJ, Marth GT, Bronner MP, Underhill H (2018). Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing. PloS one, 13(7), e0197333.
  143. Nason KS, Farrow DC, Haigh G, Lee SP, Bronner MP, Rosen SN, Vaughan T (2007). Gastric fluid bile concentrations and risk of Barrett's esophagus. Interactive cardiovascular and thoracic surgery, 6(3), 304-7.
  144. Brentnall TA, Pan S, Bronner MP, Crispin DA, Mirzaei H, Cooke K, Tamura Y, Nikolskaya T, Jebailey L, Goodlett DR, McIntosh M, Aebersold R, Rabinovitch PS, Chen (2009). Proteins That Underlie Neoplastic Progression of Ulcerative Colitis. Proteomics. Clinical applications, 3(11), 1326.
  145. Pedersen BS, Bhetariya PJ, Brown J, Kravitz SN, Marth G, Jensen RL, Bronner MP, Underhill HR, Quinlan A (2020). Somalier: rapid relatedness estimation for cancer and germline studies using efficient genome sketches. Genome medicine, 12(1), 62.
  146. Kanth P, Bronner MP, Boucher KM, Burt RW, Neklason DW, Hagedorn CH, Delker D (2016). Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype. Cancer prevention research (Philadelphia, Pa.), 9(6), 456-65.
  147. Reimel BA, Pan S, May DH, Shaffer SA, Goodlett DR, McIntosh MW, Yerian LM, Bronner MP, Chen R, Brentnall T (2009). Proteomics on Fixed Tissue Specimens - A Review. Current proteomics, 6(1), 63-69.
  148. Xiao Z, Dasari VM, Kirby DF, Bronner MP, Plesec TP, Lashner B (2009). Collagenous Sprue: A Case Report and Literature Review. Gastroenterology & hepatology, 5, 418-426.
  149. Himbert C, Figueiredo JC, Shibata D, Ose J, Lin T, Huang LC, Peoples AR, Scaife CL, Pickron B, Lambert L, Cohan JN, Bronner M, Felder S, Sanchez J, Dessureault S, Coppola D, Hoffman DM, Nasseri YF, Decker RW, Zaghiyan K, Murrell ZA, Hendifar A, Gong J, Firoozmand E, Gangi A, Moore BA, Cologne KG, El-Masry MS, Hinkle N, Monroe J, Mutch M, Bernadt C, Chatterjee D, Sinanan M, Cohen SA, Wallin U, Grady WM, Lampe PD, Reddi D, Krane M, Fichera A, Moonka R, Herpel E, Schirmacher P, Kloor M, von Knebel-Doeberitz M, Nattenmueller J, Kauczor HU, Swanson E, Jedrzkiewicz J, Schmit SL, Gigic B, Ulrich AB, Toriola AT, Siegel EM, Li CI, Ulrich CM, Hardikar (2021). Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset. Cancers, 13(15),
  150. Levi Z, Baris HN, Kedar I, Niv Y, Geller A, Gal E, Gingold R, Morgenstern S, Baruch Y, Leach BH, Bronner MP, Eng (2011). Upper and Lower Gastrointestinal Findings in PTEN Mutation-Positive Cowden Syndrome Patients Participating in an Active Surveillance Program. Clinical and translational gastroenterology, 2, e5.
  151. Kanth P, Boylan KE, Bronner MP, Boucher KM, Hazel MW, Yao R, Pop S, Bernard PS, Delker D (2019). Molecular Biomarkers of Sessile Serrated Adenoma/Polyps. Clinical and translational gastroenterology, 10(12), e00104.
  152. Runtsch MC, Hu R, Alexander M, Wallace J, Kagele D, Petersen C, Valentine JF, Welker NC, Bronner MP, Chen X, Smith DP, Ajami NJ, Petrosino JF, Round JL, O'Connell R (2015). MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis. Oncotarget, 6(30), 28556-72.
  153. Geiersbach K, Adey N, Welker N, Elsberry D, Malmberg E, Edwards S, Downs-Kelly E, Salama M, Bronner (2016). Digitally guided microdissection aids somatic mutation detection in difficult to dissect tumors. Cancer genetics, 209(1-2), 42-9.
  154. Krah NM, De La O JP, Swift GH, Hoang CQ, Willet SG, Chen Pan F, Cash GM, Bronner MP, Wright CV, MacDonald RJ, Murtaugh L (2015). The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. eLife, 4,
  155. Lin J, Zhang X, Zhao Z, Welker NC, Li Y, Liu Y, Bronner M (2016). Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing. MicroRNA (Shariqah, United Arab Emirates), 5(3), 222-229.
  156. Bronner MP, LiVolsi VA, Jennings T (1988). PLAT: Paraganglioma-Like Adenomas of the Thyroid. 1, 383-389.
  157. Bronner MP, LiVolsi V (1988). Oxyphilic (Askanazy/Hürthle cell) tumors of the thyroid: Microscopic features predict biologic behavior. 1, 137-150.
  158. Jedrzkiewicz J, Bronner MP, Salama ME, Kohan J, Rowe LR, Tai D, Malmberg E, Downs-Kelly (2018). Liver Fibrosis Quantification by Digital Whole Slide Imaging and Two Photon Microscopy with Second Harmonic Generation. 4(78),
  159. Tsai HY, Bronner MP, March JK, Valentine JF, Shroyer NF, Lai LA, Brentnall TA, Pan S, Chen (2022). Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer. Cancer letters, 549, 215915.
  160. Boylan KE, Kanth P, Delker D, Hazel MW, Boucher KM, Affolter K, Clayton F, Evason KJ, Jedrzkiewicz J, Pletneva M, Samowitz W, Swanson E, Bronner M (2023). Three pathologic criteria for reproducible diagnosis of colonic sessile serrated lesion versus hyperplastic polyp. Human pathology, 137, 25-35.
  161. Geijsen AJMR, Ulvik A, Gigic B, Kok DE, van Duijnhoven FJB, Holowatyj AN, Brezina S, van Roekel EH, Baierl A, Bergmann MM, Böhm J, Bours MJL, Brenner H, Breukink SO, Bronner MP, Chang-Claude J, de Wilt JHW, Grady WM, Grünberger T, Gumpenberger T, Herpel E, Hoffmeister M, Huang LC, Jedrzkiewicz JD, Keulen ETP, Kiblawi R, Kölsch T, Koole JL, Kosma K, Kouwenhoven EA, Kruyt FM, Kvalheim G, Li CI, Lin T, Ose J, Pickron TB, Scaife CL, Schirmacher P, Schneider MA, Schrotz-King P, Singer MC, Swanson ER, van Duijvendijk P, van Halteren HK, van Zutphen M, Vickers K, Vogelaar FJ, Wesselink E, Habermann N, Ulrich AB, Ueland PM, Weijenberg MP, Gsur A, Ulrich CM, Kampman (2020). Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival. JNCI cancer spectrum, 4(5), pkaa051.
  162. Patel N, Leffler DA, Al-Toma A, Mulder C, Elli L, Gan G, Patil P, Atsawarungruangkit A, Kuijpers KC, Del Gobbo A, Goldsmith J, Hintze Z, Pacheco MC, Vieth M, Melcher B, Salomao M, Pai R, Hart J, Olivas A, Naini B, Meyerson C, Choi WT, Kakar S, Westerhoff M, Cheng J, Gopal P, Hammer S, Moreno Prats M, Bronner MP, Robert M (2023). Clinical Data Do Not Reliably Predict Duodenal Histology at Follow-up in Celiac Disease: A 13 Center Correlative Study. The American journal of surgical pathology, 48(2), 212-220.
  163. Underhill HR, Karsy M, Davidson CJ, Hellwig S, Stevenson S, Goold EA, Vincenti S, Sellers DL, Dean C, Harrison BE, Bronner MP, Colman H, Jensen R (2024). Subclonal Cancer Driver Mutations Are Prevalent in the Unresected Peritumoral Edema of Adult Diffuse Gliomas. Cancer research, 84(7), 1149-1164.
  164. Duong VA, Enkhbayar A, Bhasin N, Senavirathna L, Preisner EC, Hoffman KL, Shukla R, Jenq RR, Cheng K, Bronner MP, Figeys D, Britton RA, Pan S, Chen (2024). A complementary metaproteomic approach to interrogate microbiome cultivated from clinical colon biopsies. Proteomics, e2400078.
  165. Leonard NB, Bronner M (2021). Giant Gastric Folds in Juvenile Polyposis. Case reports in gastroenterology, 15(3), 985-993.
  166. Tsai HY, Chen MH, Yun J, Lai LA, Valentine JF, Bronner MP, Brentnall TA, Pan S, Chen (2025). Restricting metabolic plasticity enhances stress adaptation through the modulation of PDH and HIF1A in TRAP1-depleted colon cancer. Cancer letters, 632, 217977.

Review

  1. Bronner M (2003). Gastrointestinal inherited polyposis syndromes. Modern pathology, 16(4), 359-65.
  2. Bronner M (2003). Gastrointestinal polyposis syndromes. American journal of medical genetics. Part A, 122A(4), 335-41.
  3. Bronner M (1997). Hürthle cell lesions of the thyroid. Pathology case reviews, 2, 200-209.

Book Chapter

  1. Bronner MP, Haggitt RC, Rubin C (1998). Endoscopy and Endoscopic Biopsy. 35-46.
  2. Bronner M (2008). Histopathology of Gastroesophageal Reflux Disease and Barrett's Esophagus. 2, 395-414.
  3. Rubesin SE, Bronner M (1991). Radiologic-Pathologic Concepts in Crohn's Disease. 1, 27-55.
  4. Bronner MP, Haggitt R (1993). The polyp-cancer sequence: Do all colorectal cancers arise from benign adenomas?. 3, 611-724.
  5. Bronner M (2003). Inflammatory Disorders of the Gastrointestinal Tract: Esophagus.
  6. Rubin CE, Bronner M (2003). Endoscopic mucosal biopsy.
  7. Bronner MP, Geisinger K (2006). The esophagus. 1281-1319.
  8. Bronner M (2007). Pathology of Hereditary Colorectal Cancer.

Case Report

  1. Grant GA, Wener MH, Yaziji H, Futran N, Bronner MP, Mandel N, Mayberg M (1999). Destructive tophaceous calcium hydroxyapatite tumor of the infratemporal fossa. Case report and review of the literature. Journal of neurosurgery, 90(1), 148-52.

Editorial

  1. Bronner M (1999). Gastric cancer and intestinal metaplasia. 30(7), 733.

Letter

  1. Haggitt RC, Bronner MP, Rubin C (1999). More biopsies per block. American journal of clinical pathology, 112(6), 878-81.
  2. Bronner MP, Goldblum JR, Kimmey MB, Brentnall TA, Rubin C (2004). Low-grade dysplasia in ulcerative colitis: natural history data still unknown. Gastroenterology, 127(1), 362-3; author reply 363-4.
  3. Raaka S, Huehnergarth KV, Kowdley KV, Bronner M (2002). Tissue typing for HFE mutations. Hepatology (Baltimore, Md.), 35(4), 977-8.
  4. Pan S, Brand RE, Lai LA, Dawson DW, Donahue TR, Kim S, Khalaf NI, Othman MO, Fisher WE, Bronner MP, Simeone DM, Brentnall TA, Chen (2021). Proteome heterogeneity and malignancy detection in pancreatic cyst fluids. Clinical and translational medicine, 11(8), e506.
  5. Lennerz JK, Pantanowitz L, Amin MB, Eltoum IE, Hameed MR, Kalof AN, Khanafshar E, Kunju LP, Lazenby AJ, Montone KT, Otis CN, Reid MD, Staats PN, Whitney-Miller CL, Abendroth CS, Aron M, Birdsong GG, Bleiweiss IJ, Bronner MP, Chapman J, Cipriani NA, de la Roza G, Esposito MJ, Fadare O, Ferrer K, Fletcher CD, Frishberg DP, Garcia FU, Geldenhuys L, Gill RM, Gui D, Halat S, Hameed O, Hornick JL, Huber AR, Jain D, Jhala N, Jorda M, Jorns JM, Kaplan J, Khalifa MA, Khan A, Kim GE, Lee EY, LiVolsi VA, Longacre T, Magi-Galluzzi C, McCall SJ, McPhaul L, Mehta V, Merzianu M, Miller SB, Molberg KH, Moreira AL, Naini BV, Nosé V, O'Toole K, Picken M, Prieto VG, Pullman JM, Quick CM, Reynolds JP, Rosenberg AE, Schnitt SJ, Schwartz MR, Sekosan M, Smith MT, Sohani A, Stowman A, Vanguri VK, Wang B, Watts JC, Wei S, Whitney K, Younes M, Zee S, Bracamonte E (2022). Ensuring remote diagnostics for pathologists: an open letter to the US Congress. Nature medicine, 28(12), 2453-2455.

Abstract

  1. Bronner MP, Saul S (1987). Biliary cystadenomas with mesenchymal stroma. 15, 1-7.